Quantcast

Latest Clinical research Stories

2014-08-08 12:25:01

DUBLIN, Aug. 8, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Diabetic Neuropathy Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 R&D activities in the Diabetic Neuropathy sector are growing in terms of an increase in the number of mergers and acquisitions. Big pharmaceutical companies take up later-stage products from small companies, where efficacy has already been demonstrated, thereby cutting down...

2014-08-08 08:26:15

LYNBROOK, N.Y., Aug. 8, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX(®) (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX(®) in the EU, announced today that it has injected the first patient in its placebo-controlled Phase 2 clinical trial of CCH for the treatment of lipoma. The Company expects to complete patient enrollment in this trial...

2014-08-08 08:25:48

THE WOODLANDS, Texas, Aug. 8, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 2014 Wedbush Life Sciences Management Access Conference on Tuesday, August 12, 2014 at 10:55 AM EDT in New York City. Lexicon management will provide an overview of Lexicon's clinical development programs and milestones. A webcast of the presentation will be available through Lexicon's website at www.lexpharma.com. An archived...

2014-08-08 08:25:39

REDWOOD CITY, Calif., Aug. 8, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will be participating at three upcoming investor events. Details of the three events are as follows: Canaccord 34(th) Annual Growth ConferenceDate: Wednesday August 13(th) Location: Boston,...

2014-08-07 23:10:23

Peterson & Associates is assisting patients who have undergone morcellation during a hysterectomy or fibroid removal review and initiate their legal claims regarding cancer risks. KANSAS CITY, MO (PRWEB) August 07, 2014 Peterson & Associates, P.C., an experienced defective device litigation law firm, is investigating the cancer-risks posed by power morcellators. The firm is concerned about patient safety in light of FDA safety alerts and Johnson & Johnson’s worldwide...

2014-08-07 23:08:50

Leading beauty brand Makeover Essentials have recently had the quality of their makeup industry tested. Makeover Essentials are proud to announce the results of their cosmetic range have exceeded industry standards and been FDA approved, earning them a reputation for customer safety, quality and value. London (PRWEB) August 07, 2014 The results from the industry laboratory tests showed that Makeover Essentials are at 100% compliance with FDA requirements for cosmetic safety. The FDA or...

2014-08-07 16:28:03

The Approved Gleostine(TM) Brand Name has Replaced the Discontinued Former Drug Name CeeNu® MIAMI, Aug. 7, 2014 /PRNewswire/ -- NextSource Biotechnology (NSB) is a leading specialty pharmaceutical manufacturer with a focus on identifying and developing the most viable pipeline of "matured" and "innovative drugs" in today's global healthcare market. http://photos.prnewswire.com/prnvar/20140124/FL52230LOGO The product name change from Lomustine (CCNU) to Gleostine(TM) represents the...

2014-08-06 23:02:13

Published since 2006, the Orange Paper gives detailed snapshot of clinical trials in Russia. Moscow, Russia (PRWEB) August 06, 2014 Synergy Research Group has released its Q2, 2014 Orange Paper. Published since 2006, the Synergy Orange Paper gives an unbiased and detailed view of the state of clinical trials in Russia. The report, which is issued quarterly, gives a strategic overview and drills down into additional data, such as the number of trials, top companies that initiated studies...

2014-08-06 12:29:33

SARASOTA, Fla., Aug. 6, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI) announced that the Company has made two key independent appointments to the Company's Board of Directors with the recent election of Ms. Lee M. Canaan, CFA and Mr. Edward J. McDonnell, MPH. as new directors. http://photos.prnewswire.com/prnvar/20140806/134113 Both Ms. Canaan and Mr. McDonnell have substantial expertise, experience and knowledge relevant to the Company's mission and...

2014-08-05 23:12:10

On July 25, CaCoCo Inc. informed consumers that CaCoCo “Original” and “Global Warrior” are recalled due to possible health risks. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) August 05, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on raw drinking chocolate. CaCoCo Inc. informed consumers on...


Word of the Day
kenspeckle
  • Having so marked an appearance as easily to be recognized.
This word may come from the Swedish 'kanspak,' quick at recognizing persons or things, or else from confusion with 'conspicuous.'